Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications
NCT03570099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2023-03-29
Summary
Death in overdose is the single most common cause of death in people using heroin. In Sweden, the number of drug-related overdose deaths has increased gradually since the early 1990s. The purpose of the study is to investigate the effects of a Naloxone distribution program in Skåne County. The primary issue is whether the project had an effect on overdose mortality and overdose related injuries.
Conditions
- Opioid Abuse
Interventions
- DRUG
-
Naloxone Nasal Spray
Naloxone Nasal Spray will be distributed at the addiction centres.
- OTHER
-
Historical control cohort
Historical data will be retrieved from quality registries.
Sponsors & Collaborators
-
Region Skane
lead OTHER
Principal Investigators
-
Ulf Malmqvist, MD, PhD · Region Skåne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-11
- Primary Completion
- 2020-12-31
- Completion
- 2023-07-01
Countries
- Sweden
Study Locations
More Related Trials
-
Blood Naloxone Levels Following Intradermal Injection in Humans
NCT05876572 ·Status: WITHDRAWN ·Phase: PHASE4
-
Nasal Naloxone for Narcotic Overdose
NCT01912573 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid
NCT02405988 ·Status: COMPLETED ·Phase: NA
-
Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use
NCT02158117 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Availability of Intranasal Naloxone
NCT05877118 ·Status: RECRUITING ·Phase: NA
-
Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital
NCT03518021 ·Status: COMPLETED ·Phase: PHASE3
-
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05338632 ·Status: RECRUITING ·Phase: PHASE1
-
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
NCT05886712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
NCT01717963 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of the Bioavailability of Nasal Naloxone
NCT01939444 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg
NCT06719986 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
NCT05377255 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Piloting a Naloxone Intervention in Philadelphia
NCT03305497 ·Status: COMPLETED
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
NCT04447287 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland
NCT01100853 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers
NCT05363501 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Usability Assessment of Naloxone by Community Members
NCT03309449 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1